| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4B | $5.2B | $5.6B | $5.7B | $4.1B | $1.2B | $5.2B | $1.2B |
| Cost of Revenue | — | — | $1.9B | $1.9B | $1.5B | $2.3B | $2.1B | — |
| Gross Profit | $2.8B | $3.3B | $3.7B | $3.7B | $2.6B | $0.6B | $3.2B | $0.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.6B | $2.8B | $2.7B | $2.5B | $2.0B | $2.5B | $2.1B | $1.8B |
| Operating Income | $-0.8B | $-0.2B | $0.7B | $0.9B | $0.0B | $-0.5B | $0.7B | $0.1B |
| Net Income | $-1.2B | $-0.2B | $0.6B | $0.8B | $-0.1B | $-0.6B | $0.5B | $0.0B |
| EPS (Basic) | $-10.00 | $-1.96 | $4.65 | $5.49 | $-0.41 | $-1.48 | $3.62 | $3.89 |
| EPS (Diluted) | $-10.00 | $-1.96 | $4.60 | $5.39 | $-0.41 | $-1.48 | $3.58 | $3.82 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.2B | $6.7B | $7.3B | $7.5B | $7.5B | $7.9B | $6.7B | $4.1B |
| Current Assets | $1.5B | $1.6B | $1.9B | $1.9B | $1.5B | $1.9B | $1.7B | $1.3B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.6B | $0.2B | $0.2B |
| Total Liabilities | $4.8B | $5.1B | $5.4B | $4.9B | $5.3B | $5.8B | $4.2B | $2.0B |
| Current Liabilities | $1.3B | $1.7B | $1.4B | $1.6B | $1.6B | $1.4B | $1.5B | $1.0B |
| Stockholders' Equity | $0.4B | $1.6B | $1.8B | $2.6B | $2.2B | $2.2B | $2.4B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.8B | $0.7B | $0.6B | $0.9B | $0.7B | — |
| Investing Cash Flow | $-0.1B | $-0.1B | $0.2B | $0.1B | $-0.1B | $0.1B | $-2.1B | — |
| Capital Expenditures | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.8B | $-0.8B | $-0.9B | $-0.5B | $1.5B | — |